Uniphar (UPR) H1 2025 earnings summary
Event summary combining transcript, slides, and related documents.
H1 2025 earnings summary
20 Oct, 2025Executive summary
Achieved H1 2025 revenue of €1.5bn, gross profit of €219.7m (up 6.3%), and EBITDA of €57.5m (up 2.9%), with all divisions contributing to 8.1% organic gross profit growth and 21% adjusted EPS increase.
Completed €35m share buyback, repurchasing 13.4m shares, supporting EPS growth; leverage maintained at 1.9x net bank debt/EBITDA.
ROCE reached 15.5%, exceeding the 12-15% target range.
Declared interim dividend of €0.0071 per share, up 6% from prior year, reflecting a progressive dividend policy.
Continued strategic investments in technology, infrastructure, and people to support the €200m EBITDA target by 2028.
Financial highlights
Revenue: €1,485.5m (+8.6% year-over-year); gross profit: €219.7m (+6.3%); EBITDA: €57.5m (+2.9%).
Organic gross profit growth: 8.1% across all divisions; adjusted EPS: 9.8c (up from 8.1c); ROCE: 15.5%.
Free cash flow conversion: 35.3% for H1 2025, with a target of 60%-70% by 2028.
Net bank debt: €197.5m as of June 30, 2025; leverage at 1.9x.
EBITDA margin at 3.9%; gross margin at 14.8%.
Outlook and guidance
Targeting €200m EBITDA by 2028, with at least 80% of growth expected to be organic.
Free cash flow conversion goal of 60-70% at €200m EBITDA.
Net bank debt/EBITDA not to exceed 2.5x in the medium term.
Expect organic EBITDA growth to accelerate in H2 due to investment phasing and revenue seasonality.
Progressive dividend policy and continued share buybacks subject to market conditions.
Latest events from Uniphar
- Strong organic growth, robust cash flow, and infrastructure investment drive 2028 targets.UPR
H2 202524 Feb 2026 - Achieved 21% adjusted EPS growth in 2025, with strong organic profit and positive 2026 outlook.UPR
H2 2025 TU27 Jan 2026 - Revenue up 10.3%, EBITDA up 6.3%, and all divisions delivered strong growth.UPR
H1 202422 Jan 2026 - Revenue up 8.5% to €2.77bn, EBITDA €123.5m, €35m buyback, €200m EBITDA target by 2028.UPR
H2 202423 Dec 2025